Jalen Durens AllNBA Selection Could Cost Detroit Pistons Nearly 50 Million Indias Gen Z Protests and Website Shutdown Highlight Rising Political Risk for Investors Foreign Portfolio Investors Voice Concerns Over Rupee Depreciation and Dwindling Returns at Hong Kong Conference FedExLed Consortium Set to Open 9 Billion Buyout Window for Polish Parcel Firm InPost in Late May Nio Shares Surge 10 After Launch of Chinas Largest Electric SUV OMC Stocks in Focus After Third Fuel Price Hike in Eight Days IOC BPCL HPCL Ready Capital Corporation RC Q1 2026 Earnings Deep EPS Miss as Net Loss Exceeds Expectations GLBS Q4 2025 Earnings Unexpected Profit as EPS Surges Past Estimates IIIN Q1 2026 Earnings EPS Misses Estimates as Steel Wire Demand Softens Stock Gains Despite Shortfall PB Q1 2026 Earnings EPS Misses Estimates Amid Challenging Rate Environment SWBI Q1 2026 Earnings EPS Surprises Despite Flat Market Reception QURE Q1 2026 Earnings Narrower Loss Than Expected but Stock Declines on Lack of Revenue Natural Health Trends NHTC Edges Lower as Stock Hovers Between Key Support and Resistance Levels Gladstone Capital GLAD Gains 13 as YieldDriven Demand Supports BDC Shares Tecnoglass TGLS Holds Steady Near 41 as Support and Resistance Levels Come into Focus Gibraltar Industries ROCK Holds Steady Near Support Amid Modest Decline Gores Holdings X GTEN Hovers Near 1034 as Mild Selling Pressure Keeps Stock Flat Microsofts Trusted Tech Lead Jenny LayFlurrie on Balancing Speed and Responsibility in AI Development Copa Holdings Q1 2026 Earnings Strong EPS Surprise Lifts Shares XMAX Inc XWIN Holds Steady at 824 as Consolidation Signals Trader Indecision Sunrun RUN Surges 375 as Solar Stocks Rebound Key Levels to Watch Costamare Bulkers Holdings CMDB Slips 089 as Shares Test Key Support Zone ENI SpA E Declines Over 2 as Energy Pullback Weighs on Shares SiriusXM Holdings Inc SIRI Surges Over 3 as Stock Tests Resistance Near 3141 Waldencast plc WALD Shows Resilience with 382 Gain Testing Key Resistance Marsh MRSH Slips Slightly Amid RangeBound Trading Key Levels in Focus Eupraxia Pharmaceuticals EPRX Gains 279 as Stock Tests Resistance Near 775